<html>
<body>

<p style="margin-top: 0; margin-bottom: 0" align="center">As filed with the
Securities and Exchange Commission on February__, 2005</p>
<p style="margin-top: 0; margin-bottom: 0" align="center">&nbsp;</p>
<p ALIGN="right" style="margin-top: 0; margin-bottom: 0">Registration No.
333-____________ </p>
<p ALIGN="right" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<b>
<div style="border-top: 4px double #000000">
	<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</div>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">SECURITIES AND
EXCHANGE COMMISSION</p>
</b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">Washington, D.C. 20549</p>
<u>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</p>
</u><b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">FORM S-8</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">REGISTRATION STATEMENT</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">UNDER</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">THE SECURITIES ACT OF
1933</p>
</b><u>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</p>
</u><b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">CHEMOKINE THERAPEUTICS
CORP.</p>
</b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">(Exact name of
registrant as specified in its charter)</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<table border="0" width="986" id="table1" cellspacing="1">
	<tr>
		<td align="center" width="492">
		<p style="margin-top: 0; margin-bottom: 0"><b>Delaware</b></td>
		<td align="center" width="493">
		<p style="margin-top: 0; margin-bottom: 0"><b>33-0921251</b></td>
	</tr>
	<tr>
		<td align="center" width="492">
		<p style="margin-top: 0; margin-bottom: 0">(State or other jurisdiction</td>
		<td align="center" width="493">
		<p style="margin-top: 0; margin-bottom: 0">&nbsp;(IRS
		Employer Identification No.)</td>
	</tr>
	<tr>
		<td align="center" width="492">
		<p style="margin-top: 0; margin-bottom: 0">of incorporation or
		organization)</td>
	</tr>
</table>
<b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">2386 East Mall, Suite
208</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">University of British
Columbia</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">Vancouver, British
Columbia V6T 1Z3</p>
</b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">(Address of principal
executive offices) (Zip Code)</p>
<u>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
</u><b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">CHEMOKINE THERAPEUTICS
CORP. 2004 STOCK OPTION PLAN</p>
</b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">(Full title of the
Plan)</p>
<u>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</p>
</u><b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">The Corporation Trust
Company</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">Corporation Trust
Center</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">1209 Orange Street</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">Wilmington, DE 19801</p>
</b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">(Name and address of
agent for service)</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">302-777-0247</p>
</b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">(Telephone number,
including area code, of agent for service)</p>
<u>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
</u><b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">CALCULATION OF
REGISTRATION FEE</p>
<div style="border-bottom: 4px double #000000">
	<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</div>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
</b><center>
<div align="left">
	<table BORDER="0" CELLSPACING="1" WIDTH="100%">
		<tr>
			<td WIDTH="29%" VALIGN="bottom" HEIGHT="55" style="border-style: solid; border-width: 1px" bordercolor="#000000">
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0"><u>Title
			of Securities to be Registered</u></td>
			<td WIDTH="18%" VALIGN="bottom" HEIGHT="55" style="border-style: solid; border-width: 1px" bordercolor="#000000">
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0"><u>Amount
			to be Registered(1)</u></td>
			<td WIDTH="18%" VALIGN="bottom" HEIGHT="55" style="border-style: solid; border-width: 1px" bordercolor="#000000">
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">Proposed
			Maximum
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0"><u>Offering Price per Share</u></td>
			<td WIDTH="18%" VALIGN="bottom" HEIGHT="55" style="border-style: solid; border-width: 1px" bordercolor="#000000">
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">Proposed
			Maximum<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;<u>Aggregate Offering Price(2)</u></td>
			<td WIDTH="18%" VALIGN="bottom" HEIGHT="55" style="border-style: solid; border-width: 1px" bordercolor="#000000">
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">Amount of
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0"><u>Registration Fee</u></td>
		</tr>
		<tr>
			<td WIDTH="29%" VALIGN="MIDDLE" HEIGHT="40" style="border-style: solid; border-width: 1px" bordercolor="#000000">
			<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">Chemokine
			Therapeutics Corp.</p>
			<u>
			<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">2004
			Stock Option Plan</p>
			</u>
			<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">Common
			Stock, $0.001 par value</td>
			<td WIDTH="18%" VALIGN="TOP" HEIGHT="40" style="border-style: solid; border-width: 1px" bordercolor="#000000">
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">4,550,416</td>
			<td WIDTH="18%" VALIGN="TOP" HEIGHT="40" style="border-style: solid; border-width: 1px" bordercolor="#000000">
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">$0.90(2)</td>
			<td WIDTH="18%" VALIGN="TOP" HEIGHT="40" style="border-style: solid; border-width: 1px" bordercolor="#000000">
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">
			$4,095,374.40(2)</td>
			<td WIDTH="18%" VALIGN="TOP" HEIGHT="40" style="border-style: solid; border-width: 1px" bordercolor="#000000">
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
			<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">$482.03</td>
		</tr>
	</table>
</div>
</center><font SIZE="1"><u></u></font>
<ol>
	<li>
	<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 20px">This
	Registration Statement shall also cover any additional shares of Common
	Stock which become issuable under the Chemokine Therapeutics Corp.'s 2004
	Stock Option Plan by reason of any stock dividend, stock split,
	recapitalization or other similar transaction effected without the
	Registrant's receipt of consideration which results in an increase in the
	number of the outstanding shares of the Registrant's Common Stock.</li>
	<li>
	<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 20px">Estimated,
	solely for purposes of calculating the registration fee, pursuant to Rule
	457(h) of the Securities Act of 1933, as amended, on the basis of CDN$1.12,
	the closing sales price per share of Common Stock of Chemokine Therapeutics
	Corp. on February 11, 2005, as reported by the Toronto Stock Exchange.
	Proposed maximum offering price per security shown in U.S. dollars converted
	at CDN$1.2379 per US$1.00.</li>
</ol>
<hr><b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">PART II</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">Information Required
in the Registration Statement</p>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
</b>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">Item 3. <u>
Incorporation of Documents by Reference</p>
</u>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Chemokine Therapeutics Corp. (the &quot;Registrant&quot;) hereby incorporates by reference
into this Registration Statement the following documents, and any amendments
thereto, previously filed with the Securities and Exchange Commission (the
&quot;Commission&quot;):</p>
<ol type="a">
	<li>
	<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 20px">The
	Registrant's prospectus filed pursuant to Rule 424(b)(3) promulgated under
	the Securities Act of 1933, as amended (the &quot;1933 Act&quot;), with the Commission
	on December 22, 2004, in connection with the Registrant's Registration
	Statement No. 333-117858, filed with the Commission on December 17, 2004, in
	which there is set forth the audited financial statements for the
	Registrant's fiscal year ended December 31, 2003.</li>
	<li>
	<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 20px">The
	Registrant's Registration Statement No. 000-51080 on Form 8-A filed with the
	Commission on December 17, 2004, pursuant to Section 12 of the Securities
	Exchange Act of 1934, as amended (the &quot;1934 Act&quot;), in which there is
	described the terms, rights and provisions applicable to the Registrant's
	outstanding Common Stock and any amendments or reports thereto filed with
	the Commission for the purpose of updating such description.</li>
</ol>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
All reports and definitive proxy or information statements filed pursuant to
Section&nbsp;13(a), 13(c), 14 or 15(d) of the 1934 Act, after the date of this
Registration Statement and prior to the filing of a post-effective amendment
which indicates that all securities offered hereby have been sold or which
de-registers all securities then remaining unsold shall be deemed to be
incorporated by reference into this Registration Statement and to be a part
hereof from the date of filing of such documents, provided, however, that unless
expressly incorporated into this Registration Statement, a report furnished on
Form 8-K shall not be incorporated by reference into this Registration
Statement.</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Any statement contained in a document incorporated or deemed to be incorporated
by reference herein shall be deemed to be modified or superseded for purposes of
this Registration Statement to the extent that a statement contained herein or
in any subsequently filed document which also is deemed to be incorporated by
reference herein modifies or supersedes such statement. Any such statement so
modified or superseded shall not be deemed, except as so modified or superseded,
to constitute a part of this Registration Statement.</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">Item 4. <u>
Description of Securities</p>
</u><b>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</b>Not Applicable.</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">Item 5. <u>Interests
of Named Experts and Counsel</p>
</u>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Not Applicable.</p>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p style="margin-top: 0; margin-bottom: 0">Item 6. <u>Indemnification of
Directors and Officers</p>
</u>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
As provided in the Registrant's bylaws and under Delaware law, the Registrant's
directors shall not be personally liable to the Registrant or any other person
for monetary damages for breach of duty of care or any other duty owed to the
Registrant as a director, unless the breach of or failure to perform those
duties constitutes:</p>
<dir>
	<li>
	<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 20px">a violation of
	criminal law, unless the director had reasonable cause to believe his
	conduct was lawful, or had no reasonable cause to believe his conduct was
	unlawful;</li>
	<li>
	<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 20px">a transaction
	from which the director received an improper personal benefit, directly or
	indirectly;</li>
	<li>
	<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 20px">an act or
	omission which involves a conscious disregard for our best interests or
	which involves willful misconduct;</li>
</dir>
<p ALIGN="center" style="margin-top: 0; margin-bottom: 0">II-1</p>
<p ALIGN="center" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<hr>
<dir>
	<li>
	<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 20px">an act of
	recklessness or an act or omission which was committed in bad faith or with
	malicious purpose or in a manner exhibiting wanton and willful disregard of
	human rights, safety, or property; or</li>
	<li>
	<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 20px">a distribution
	made in violation of Delaware law.</li>
</dir>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Registrant's bylaws provides that the Registrant shall indemnify any
director, officer, employee or agent made a party to a proceeding because he is
or was the Registrant's director, officer, employee or agent against liability
incurred in the proceeding if he acted in good faith and in a manner the person
reasonably believed to be in or not opposed to the Registrant's best interests
and, in the case of any criminal proceeding, he had no reasonable cause to
believe his conduct was unlawful.</p>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Registrant's bylaws and Delaware law also provide that the Registrant shall
indemnify a director, officer, employee or agent who has been successful on the
merits or otherwise in the defense of any proceeding to which he was a party, or
in defense of any claim, issue or matter therein, because he is or was a
director, officer, employee or agent of the Registrant against expenses actually
and reasonably incurred by him in connection with such defense.</p>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">Item 7. <u>Exemption
from Registration Claimed</p>
</u>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Not Applicable.</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">Item 8. <u>Exhibits</p>
</u>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<table border="0" width="100%" id="table2" cellspacing="1">
	<tr>
		<td>
		<p style="margin-top: 0; margin-bottom: 0"><u>Exhibit Number</u></td>
		<td width="834">
		<p style="margin-top: 0; margin-bottom: 0"><u>&nbsp;Exhibit</u></td>
	</tr>
	<tr>
		<td>
		<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">5&nbsp;&nbsp;
		</td>
		<td width="834">
		<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">Opinion
		and Consent of Squire, Sanders &amp; Dempsey L.L.P.</td>
	</tr>
	<tr>
		<td>
		<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">23.1&nbsp;&nbsp;
		</td>
		<td width="834">
		<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">Consent
		of Independent Registered Public Accounting Firm.</td>
	</tr>
	<tr>
		<td>
		<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">23.2&nbsp;&nbsp;
		</td>
		<td width="834">
		<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">Consent
		of Squire, Sanders &amp; Dempsey L.L.P. is contained in Exhibit 5.</td>
	</tr>
	<tr>
		<td>
		<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">24&nbsp;&nbsp;
		</td>
		<td width="834">
		<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">Power
		of Attorney. Reference is made to page II-4 of this Registration
		Statement.</td>
	</tr>
	<tr>
		<td>
		<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">99.1&nbsp;&nbsp;
		</td>
		<td width="834">
		<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">Chemokine
		Therapeutics Corp. 2004 Stock Option Plan. (Filed on October 20, 2004,
		as part of Amendment No. One to Form SB-2 Registration Statement.)</td>
	</tr>
</table>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">Item 9. <u>
Undertakings</u></p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
A. The undersigned Registrant hereby undertakes: (1)&nbsp;to file, during any period
in which offers or sales are being made, a post-effective amendment to this
Registration Statement: (i)&nbsp;to include any prospectus required by
Section&nbsp;10(a)(3) of the 1933 Act, (ii)&nbsp;to reflect in the prospectus any facts or
events arising after the effective date of this Registration Statement (or the
most recent post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set forth in this
Registration Statement and (iii)&nbsp;to include any material information with
respect to the plan of distribution not previously disclosed in this
Registration Statement or any material change to such information in this
Registration Statement; provided, however, that clauses&nbsp;(1)(i) and (1)(ii) shall
not apply if the information required to be included in a post-effective
amendment by those clauses is contained in periodic reports filed by the
Registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the 1934 Act that are
incorporated by reference into this Registration Statement; (2)&nbsp;that for the
purpose of determining any liability under the 1933 Act each such post-effective
amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof; and (3) to remove
from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the Registrant's 2004
Stock Incentive Plan.</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
B. The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the 1933 Act, each filing of the Registrant's
annual report pursuant to Section&nbsp;13(a) or Section 15(d) of the 1934 Act that is
incorporated by reference into this Registration Statement shall be deemed to be
a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.</p>
<p ALIGN="center" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="center" style="margin-top: 0; margin-bottom: 0">II-2</p>
<hr>
<p ALIGN="center" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
C. Insofar as indemnification for liabilities arising under the 1933 Act may be
permitted to directors, officers or controlling persons of the Registrant
pursuant to the indemnification provisions summarized in Item 6 or otherwise,
the Registrant has been advised that, in the opinion of the Commission, such
indemnification is against public policy as expressed in the 1933 Act and is,
therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the Registrant of expenses incurred
or paid by a director, officer, or controlling person of the Registrant in the
successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the 1933 Act and will be governed by the final
adjudication of such issue.</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">[<i>Remainder of Page
Left Intentionally Blank.</i>]</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">II-3</p>
<hr>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<b>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">SIGNATURES</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
</b>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">Pursuant to the
requirements of the Securities Act of 1933, as amended, the Registrant certifies
that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-8, and has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly authorized, in the City
of Los Angeles, California on this 10th day of February, 2005.</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0"><b>CHEMOKINE
THERAPEUTICS CORP.</p>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
</b>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">By:<u>/s/ Hassan
Salari&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</u></p>
<p style="margin-top: 0; margin-bottom: 0">Hassan Salari</p>
<p style="margin-top: 0; margin-bottom: 0">President and Chief Executive Officer</p>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p><font SIZE="2">
</font><b><u>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">POWER OF ATTORNEY</p>
</u>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">KNOW ALL PERSONS BY
THESE PRESENTS:</p>
</b>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; That each person
whose signature appears below constitutes and appoints Hassan Salari, President
and Chief Executive Officer, and David Karp, Chief Financial Officer, and each
of them, as such person's true and lawful attorneys-in-fact and agents, with
full power of substitution and resubstitution, for such person and in such
person's name, place and stead, in any and all capacities, to sign any and all
amendments (including post-effective amendments) to this Registration Statement,
and to file same, with all exhibits thereto, and other documents in connection
therewith, with the Securities and Exchange Commission, granting unto said
attorneys-in-fact and agents, and each of them, full power and authority to do
and perform each and every act and thing requisite and necessary to be done in
connection therewith, as fully to all intents and purposes as such person might
or could do in person, hereby ratifying and confirming all that said
attorneys-in-fact and agents, or any of them, or their or his or her
substitutes, may lawfully do or cause to be done by virtue thereof.</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pursuant to the
requirements of the Securities Act of 1933, as amended, this Registration
Statement has been signed below by the following persons on behalf of the
Registrant and in the capacities and on the dates indicated:</p>
<p ALIGN="JUSTIFY" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<table BORDER="0" CELLSPACING="1" WIDTH="100%">
	<tr>
		<td WIDTH="29%" VALIGN="TOP"><b>
		<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">Signature</b></td>
		<td WIDTH="50%" VALIGN="TOP"><b>
		<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">Title</b></td>
		<td WIDTH="20%" VALIGN="TOP" align="center"><b>
		<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">Date</b></td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
		</u></td>
		<td WIDTH="50%" VALIGN="BOTTOM">
		<p style="margin-top: 0; margin-bottom: 0">President and Chief Executive
		Officer and Member of the Board of Directors</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">
		<p style="margin-top: 0; margin-bottom: 0">February 10, 2005</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP"><b>
		<p style="margin-top: 0; margin-bottom: 0">Hassan Salari </b></td>
		<td WIDTH="50%" VALIGN="BOTTOM">&nbsp;</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">&nbsp;</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP">
		&nbsp;</td>
		<td WIDTH="50%" VALIGN="BOTTOM">
		&nbsp;</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">
		&nbsp;</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP">
		<p style="margin-top: 0; margin-bottom: 0"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
		</u>
		</td>
		<td WIDTH="50%" VALIGN="BOTTOM">
		<p style="margin-top: 0; margin-bottom: 0">Chief Financial Officer</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">
		<p style="margin-top: 0; margin-bottom: 0">February 10, 2005</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP"><b>
		<p style="margin-top: 0; margin-bottom: 0">David Karp</b></td>
		<td WIDTH="50%" VALIGN="BOTTOM">&nbsp;</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">&nbsp;</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP">
		&nbsp;</td>
		<td WIDTH="50%" VALIGN="BOTTOM">
		&nbsp;</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">
		&nbsp;</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP">
		<p style="margin-top: 0; margin-bottom: 0"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
		</u>
		</td>
		<td WIDTH="50%" VALIGN="BOTTOM">
		<p style="margin-top: 0; margin-bottom: 0">Member of the Board of
		Directors</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">
		<p style="margin-top: 0; margin-bottom: 0">February 10, 2005</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP"><b>
		<p style="margin-top: 0; margin-bottom: 0">Matthias C. Kurth</b></td>
		<td WIDTH="50%" VALIGN="BOTTOM">&nbsp;</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">&nbsp;</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP">
		&nbsp;</td>
		<td WIDTH="50%" VALIGN="BOTTOM">
		&nbsp;</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">
		&nbsp;</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP">
		<p style="margin-top: 0; margin-bottom: 0"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
		</u>
		</td>
		<td WIDTH="50%" VALIGN="BOTTOM">
		<p style="margin-top: 0; margin-bottom: 0">Member of the Board of
		Directors</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">
		<p style="margin-top: 0; margin-bottom: 0">February 10, 2005</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP"><b>
		<p style="margin-top: 0; margin-bottom: 0">Michael Evans</b></td>
		<td WIDTH="50%" VALIGN="BOTTOM">&nbsp;</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">&nbsp;</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP">&nbsp;</td>
		<td WIDTH="50%" VALIGN="BOTTOM">
		&nbsp;</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">
		&nbsp;</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP">
		<p style="margin-top: 0; margin-bottom: 0"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
		</u></td>
		<td WIDTH="50%" VALIGN="BOTTOM">
		<p style="margin-top: 0; margin-bottom: 0">Member of the Board of
		Directors</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">
		<p style="margin-top: 0; margin-bottom: 0">February 10, 2005</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP"><b>
		<p style="margin-top: 0; margin-bottom: 0">John Osth</b></td>
		<td WIDTH="50%" VALIGN="BOTTOM">&nbsp;</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">&nbsp;</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP">&nbsp;</td>
		<td WIDTH="50%" VALIGN="BOTTOM">
		&nbsp;</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">
		&nbsp;</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP">
		<p style="margin-top: 0; margin-bottom: 0"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
		</u></td>
		<td WIDTH="50%" VALIGN="BOTTOM">
		<p style="margin-top: 0; margin-bottom: 0">Member of the Board of
		Directors</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">
		<p style="margin-top: 0; margin-bottom: 0">February 10, 2005</td>
	</tr>
	<tr>
		<td WIDTH="29%" VALIGN="TOP"><b>
		<p style="margin-top: 0; margin-bottom: 0">C. Richard Piazza</b></td>
		<td WIDTH="50%" VALIGN="BOTTOM">&nbsp;</td>
		<td WIDTH="20%" VALIGN="TOP" align="center">&nbsp;</td>
	</tr>
</table>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p ALIGN="CENTER" style="margin-top: 0; margin-bottom: 0">II-4</p><hr>

</body>

</html>
[{"type": "S-8", "sequence": "1", "filename": "chemokine-s8_21405.htm", "secsgml_size_bytes": 35218}]
{"company-data": {"conformed-name": "CHEMOKINE THERAPEUTICS CORP", "cik": "0001092959", "assigned-sic": "2836", "irs-number": "330921251", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-122868", "film-number": "05623290"}, "business-address": {"street1": "2386 EAST MALL STREET., SUITE 208", "street2": "SUITE 208", "city": "VANCOUVER", "state": "A1", "zip": "V6T 1Z3", "phone": "604-8220301"}, "mail-address": {"street1": "2386 EAST MALL STREET., SUITE 208", "city": "VANCOUVER", "state": "A1", "zip": "V6T 1Z3"}, "former-company": {"former-conformed-name": "PTM MOLECULAR BIOSYSTEMS INC", "date-changed": "20000204"}}
As filed with the
Securities and Exchange Commission on February__, 2005
Registration No.
333-____________
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF
1933
CHEMOKINE THERAPEUTICS
CORP.
(Exact name of
registrant as specified in its charter)
Delaware
33-0921251
(State or other jurisdiction
(IRS
		Employer Identification No.)
of incorporation or
		organization)
2386 East Mall, Suite
208
University of British
Columbia
Vancouver, British
Columbia V6T 1Z3
(Address of principal
executive offices) (Zip Code)
CHEMOKINE THERAPEUTICS
CORP. 2004 STOCK OPTION PLAN
(Full title of the
Plan)
The Corporation Trust
Company
Corporation Trust
Center
1209 Orange Street
Wilmington, DE 19801
(Name and address of
agent for service)
302-777-0247
(Telephone number,
including area code, of agent for service)
CALCULATION OF
REGISTRATION FEE
Title
			of Securities to be Registered
Amount
			to be Registered(1)
Proposed
			Maximum
Offering Price per Share
Proposed
			Maximum
Aggregate Offering Price(2)
Amount of
Registration Fee
Chemokine
			Therapeutics Corp.
2004
			Stock Option Plan
Common
			Stock, $0.001 par value
4,550,416
$0.90(2)
$4,095,374.40(2)
$482.03
This
	Registration Statement shall also cover any additional shares of Common
	Stock which become issuable under the Chemokine Therapeutics Corp.'s 2004
	Stock Option Plan by reason of any stock dividend, stock split,
	recapitalization or other similar transaction effected without the
	Registrant's receipt of consideration which results in an increase in the
	number of the outstanding shares of the Registrant's Common Stock.
Estimated,
	solely for purposes of calculating the registration fee, pursuant to Rule
	457(h) of the Securities Act of 1933, as amended, on the basis of CDN$1.12,
	the closing sales price per share of Common Stock of Chemokine Therapeutics
	Corp. on February 11, 2005, as reported by the Toronto Stock Exchange.
	Proposed maximum offering price per security shown in U.S. dollars converted
	at CDN$1.2379 per US$1.00.
PART II
Information Required
in the Registration Statement
Item 3.
Incorporation of Documents by Reference
Chemokine Therapeutics Corp. (the "Registrant") hereby incorporates by reference
into this Registration Statement the following documents, and any amendments
thereto, previously filed with the Securities and Exchange Commission (the
"Commission"):
The
	Registrant's prospectus filed pursuant to Rule 424(b)(3) promulgated under
	the Securities Act of 1933, as amended (the "1933 Act"), with the Commission
	on December 22, 2004, in connection with the Registrant's Registration
	Statement No. 333-117858, filed with the Commission on December 17, 2004, in
	which there is set forth the audited financial statements for the
	Registrant's fiscal year ended December 31, 2003.
The
	Registrant's Registration Statement No. 000-51080 on Form 8-A filed with the
	Commission on December 17, 2004, pursuant to Section 12 of the Securities
	Exchange Act of 1934, as amended (the "1934 Act"), in which there is
	described the terms, rights and provisions applicable to the Registrant's
	outstanding Common Stock and any amendments or reports thereto filed with
	the Commission for the purpose of updating such description.
All reports and definitive proxy or information statements filed pursuant to
Section 13(a), 13(c), 14 or 15(d) of the 1934 Act, after the date of this
Registration Statement and prior to the filing of a post-effective amendment
which indicates that all securities offered hereby have been sold or which
de-registers all securities then remaining unsold shall be deemed to be
incorporated by reference into this Registration Statement and to be a part
hereof from the date of filing of such documents, provided, however, that unless
expressly incorporated into this Registration Statement, a report furnished on
Form 8-K shall not be incorporated by reference into this Registration
Statement.
Any statement contained in a document incorporated or deemed to be incorporated
by reference herein shall be deemed to be modified or superseded for purposes of
this Registration Statement to the extent that a statement contained herein or
in any subsequently filed document which also is deemed to be incorporated by
reference herein modifies or supersedes such statement. Any such statement so
modified or superseded shall not be deemed, except as so modified or superseded,
to constitute a part of this Registration Statement.
Item 4.
Description of Securities
Not Applicable.
Item 5.
Interests
of Named Experts and Counsel
Not Applicable.
Item 6.
Indemnification of
Directors and Officers
As provided in the Registrant's bylaws and under Delaware law, the Registrant's
directors shall not be personally liable to the Registrant or any other person
for monetary damages for breach of duty of care or any other duty owed to the
Registrant as a director, unless the breach of or failure to perform those
duties constitutes:
a violation of
	criminal law, unless the director had reasonable cause to believe his
	conduct was lawful, or had no reasonable cause to believe his conduct was
	unlawful;
a transaction
	from which the director received an improper personal benefit, directly or
	indirectly;
an act or
	omission which involves a conscious disregard for our best interests or
	which involves willful misconduct;
II-1
an act of
	recklessness or an act or omission which was committed in bad faith or with
	malicious purpose or in a manner exhibiting wanton and willful disregard of
	human rights, safety, or property; or
a distribution
	made in violation of Delaware law.
The Registrant's bylaws provides that the Registrant shall indemnify any
director, officer, employee or agent made a party to a proceeding because he is
or was the Registrant's director, officer, employee or agent against liability
incurred in the proceeding if he acted in good faith and in a manner the person
reasonably believed to be in or not opposed to the Registrant's best interests
and, in the case of any criminal proceeding, he had no reasonable cause to
believe his conduct was unlawful.
The Registrant's bylaws and Delaware law also provide that the Registrant shall
indemnify a director, officer, employee or agent who has been successful on the
merits or otherwise in the defense of any proceeding to which he was a party, or
in defense of any claim, issue or matter therein, because he is or was a
director, officer, employee or agent of the Registrant against expenses actually
and reasonably incurred by him in connection with such defense.
Item 7.
Exemption
from Registration Claimed
Not Applicable.
Item 8.
Exhibits
Exhibit Number
Exhibit
5
Opinion
		and Consent of Squire, Sanders & Dempsey L.L.P.
23.1
Consent
		of Independent Registered Public Accounting Firm.
23.2
Consent
		of Squire, Sanders & Dempsey L.L.P. is contained in Exhibit 5.
24
Power
		of Attorney. Reference is made to page II-4 of this Registration
		Statement.
99.1
Chemokine
		Therapeutics Corp. 2004 Stock Option Plan. (Filed on October 20, 2004,
		as part of Amendment No. One to Form SB-2 Registration Statement.)
Item 9.
Undertakings
A. The undersigned Registrant hereby undertakes: (1) to file, during any period
in which offers or sales are being made, a post-effective amendment to this
Registration Statement: (i) to include any prospectus required by
Section 10(a)(3) of the 1933 Act, (ii) to reflect in the prospectus any facts or
events arising after the effective date of this Registration Statement (or the
most recent post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set forth in this
Registration Statement and (iii) to include any material information with
respect to the plan of distribution not previously disclosed in this
Registration Statement or any material change to such information in this
Registration Statement; provided, however, that clauses (1)(i) and (1)(ii) shall
not apply if the information required to be included in a post-effective
amendment by those clauses is contained in periodic reports filed by the
Registrant pursuant to Section 13 or Section 15(d) of the 1934 Act that are
incorporated by reference into this Registration Statement; (2) that for the
purpose of determining any liability under the 1933 Act each such post-effective
amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof; and (3) to remove
from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the Registrant's 2004
Stock Incentive Plan.
B. The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the 1933 Act, each filing of the Registrant's
annual report pursuant to Section 13(a) or Section 15(d) of the 1934 Act that is
incorporated by reference into this Registration Statement shall be deemed to be
a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
II-2
C. Insofar as indemnification for liabilities arising under the 1933 Act may be
permitted to directors, officers or controlling persons of the Registrant
pursuant to the indemnification provisions summarized in Item 6 or otherwise,
the Registrant has been advised that, in the opinion of the Commission, such
indemnification is against public policy as expressed in the 1933 Act and is,
therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the Registrant of expenses incurred
or paid by a director, officer, or controlling person of the Registrant in the
successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the 1933 Act and will be governed by the final
adjudication of such issue.
[
Remainder of Page
Left Intentionally Blank.
]
II-3
SIGNATURES
Pursuant to the
requirements of the Securities Act of 1933, as amended, the Registrant certifies
that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-8, and has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly authorized, in the City
of Los Angeles, California on this 10th day of February, 2005.
CHEMOKINE
THERAPEUTICS CORP.
By:
/s/ Hassan
Salari
Hassan Salari
President and Chief Executive Officer
POWER OF ATTORNEY
KNOW ALL PERSONS BY
THESE PRESENTS:
That each person
whose signature appears below constitutes and appoints Hassan Salari, President
and Chief Executive Officer, and David Karp, Chief Financial Officer, and each
of them, as such person's true and lawful attorneys-in-fact and agents, with
full power of substitution and resubstitution, for such person and in such
person's name, place and stead, in any and all capacities, to sign any and all
amendments (including post-effective amendments) to this Registration Statement,
and to file same, with all exhibits thereto, and other documents in connection
therewith, with the Securities and Exchange Commission, granting unto said
attorneys-in-fact and agents, and each of them, full power and authority to do
and perform each and every act and thing requisite and necessary to be done in
connection therewith, as fully to all intents and purposes as such person might
or could do in person, hereby ratifying and confirming all that said
attorneys-in-fact and agents, or any of them, or their or his or her
substitutes, may lawfully do or cause to be done by virtue thereof.
Pursuant to the
requirements of the Securities Act of 1933, as amended, this Registration
Statement has been signed below by the following persons on behalf of the
Registrant and in the capacities and on the dates indicated:
Signature
Title
Date
President and Chief Executive
		Officer and Member of the Board of Directors
February 10, 2005
Hassan Salari
Chief Financial Officer
February 10, 2005
David Karp
Member of the Board of
		Directors
February 10, 2005
Matthias C. Kurth
Member of the Board of
		Directors
February 10, 2005
Michael Evans
Member of the Board of
		Directors
February 10, 2005
John Osth
Member of the Board of
		Directors
February 10, 2005
C. Richard Piazza
II-4